Skip to content Skip to navigation

News and Press Releases

Jul 29 2020 | Stanford News
Stanford chemists have developed a new tool that shuttles unwanted cell surface proteins to their deaths.
Jul 2 2020 | Stanford ChEM-H
New research from Stanford recasts the brain vasculature, commonly known as the “blood-brain barrier,” as an active interface that, contrary to other theories, allows many proteins from the blood into brain cells.
Jun 29 2020 | Scope
The antiviral drug remdesivir has been approved for emergency use among hospitalized COVID-19 patients, and in recent studies, has shown promise as a treatment for the pandemic disease.
Jun 25 2020 | Scope
To get up to speed on the revolutionary pace of coronavirus vaccine development, Paul Costello spoke to Stanford Medicine's Bali Pulendran, PhD, a professor of pathology and of microbiology and immunology for a 1:2:1 podcast.
Jun 25 2020 | Stanford Engineering
Chemical engineering Professor Gerald Fuller has received the Tau Beta Pi Teaching Award for the 2019–2020 academic year, and 12 other faculty members and instructors have been added to the Teaching Honor Roll by the Stanford chapter of this nationwide honors society for the engineering profession.
Jun 25 2020 | Stanford Medicine
The Stanford-based center’s affiliated faculty and staff, aided by more than 400 volunteers, conduct research on Alzheimer’s and Parkinson’s diseases and related disorders.
Jun 24 2020 | Stanford ChEM-H
ChEM-H Undergrad Scholar and graduating senior Anthony Flores talks to us about jumping into research, directed evolution, and important mentors from his Stanford career.
Jun 23 2020 | Stanford Medicine
Specialized cells at the leading edge of growing skin cancers dampen immune response and promote cancer invasion, Stanford researchers find. Targeting these cells could lead to effective therapies.
Jun 10 2020 | Stanford Medicine
The Chan Zuckerberg Initiative has awarded $1.49 million to research projects involving Stanford Medicine scientists who will investigate emerging ideas about the role of inflammation in disease.
By making two different alterations to a single messenger protein, researchers induced the body’s biochemical control system to target two very different conditions.
Jun 8 2020 | SLAC
Researchers expect the new method to answer fundamental questions in biology and materials science. First up: Images showing molecules that help guide cell division in bacteria.
Jun 4 2020 | Stanford News
Stanford Vice Provost and Dean of Research Kathryn Moler wants all research resources to be as readily available as books in a library. This model would enable faculty and students to pursue the most innovative research in flexible, collaborative teams.
May 27 2020 | Stanford Engineering
Stanford researchers used computer simulations to pave the way for the discovery of safer, more effective medicines.
May 26 2020 | Stanford ChEM-H
ChEM-H graduate students reveal how the forest of sugars on a cell’s surface could help in the defense against flu infection.
May 22 2020 | Stanford News
At the Academic Council meeting, President Marc Tessier-Lavigne discussed how Stanford is pivoting its Long-Range Vision in light of COVID-19. ChEM-H Baker Family Co-Director, Professor Chaitan Khosla, described the new Innovative Medicines Accelerator.
May 21 2020 | Stanford News
Plans for Stanford’s new Innovative Medicines Accelerator arose before the COVID-19 pandemic struck, but now its programs are focused entirely on helping faculty generate and test new medicines to slow the spread of the disease.
May 14 2020 | Stanford ChEM-H
ChEM-H student Kolade Adebowale awarded National Institutes of Health fellowship for research at the intersection of materials science and cancer therapy.
Most vaccines direct the adaptive immune system to fight off infections with one arm tied behind its back. A new study in monkeys untied the other arm.
May 11 2020 | Stanford Medicine
Scientists at Stanford Medicine are investigating whether a molecule called interferon-lambda can help people with mild cases of COVID-19 feel better and reduce their transmission of the disease-causing virus.
May 11 2020 | Stanford News
Researchers have developed a way to combine insulin with a second hormone known as amylin, to create a two-in-one injection that could, if proven safe and effective in human trials, make it easier for diabetics to more effectively control their blood sugar levels.


Subscribe to